NCT02621892 · Interventional trial
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Overall registry status Completed
Phase 3
Conditions Constipation Predominant Irritable Bowel Syndrome
Delaware Valley sites
- Ardelyx Investigative Site 144 · Jenkintown, PA · Montgomery County
First posted
Registry updated
Added to the directory